TORONTO, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company developing AI-powered, incision-free ...
Profound Medical (Nasdaq: PROF) has received FDA 510(k) clearance for its second AI model aimed at treating prostate cancer. Profound Medical is a Toronto-based company, which specializes in ...
Francis Medical has just received a fresh infusion of cash on its journey to treat prostate cancer. This week, the Maple Grove-based company announced that it has closed on an $80 million Series C ...
MINNEAPOLIS, Feb. 25, 2025 /PRNewswire/ -- Francis Medical, Inc., a privately held medical device company developing an innovative and proprietary water vapor ablation therapy for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback